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Abstract – Word Count 243 35 
Background:  Sepsis represents a significant public health burden, costing the NHS 36 
£2.5 billion annually, with 35% mortality in 2006. The aim of this exploratory study was 37 
to investigate risk factors predictive of 30-day mortality amongst patients with sepsis in 38 
Nottingham. 39 
Methods: Data was collected prospectively from adult patients with sepsis in 40 
Nottingham University Hospitals NHS Trust as part of an on-going quality improvement 41 
project between November 2011 and March 2014. Patients admitted to critical care with 42 
the diagnosis of sepsis were included in the study. 97 separate variables were 43 
investigated for their association with 30-day mortality. Variables included patient 44 
demographics, symptoms of SIRS (systemic inflammatory response syndrome), organ 45 
dysfunction or tissue hypoperfusion, locations of early care, source of sepsis and time to 46 
interventions.  47 
Results: 455 patients were included in the study. Increased age (adjOR=1.05 48 
95%CI=1.03-1.07 p<0.001), thrombocytopenia (adjOR=3.10 95%CI=1.23-7.82 49 
p=0.016), hospital-acquired sepsis (adjOR=3.34 95%CI=1.78-6.27 p<0.001), increased 50 
lactate concentration (adjOR=1.16 95%CI=1.06-1.27 p=0.001), remaining hypotensive 51 
after vasopressors (adjOR=3.89 95%CI=1.26-11.95 p=0.02) and mottling (adjOR=3.80 52 
95%CI=1.06-13.55 p=0.04) increased 30-day mortality odds. Conversely, fever 53 
(adjOR=0.46 95%CI=0.28-0.75 p=0.002), fluid refractory hypotension (adjOR=0.29 54 
95%CI=0.10-0.87 p=0.027) and being diagnosed on surgical wards (adjOR=0.35 55 
95%CI=0.15-0.81 p=0.015) were protective. Treatment timeliness were not significant 56 
factors.  57 
Conclusion: Several important predictors of 30 day mortality were found by this 58 
research. Retrospective analysis of our sepsis data has revealed mortality predictors 59 
which appear to be more patient related than intervention specific. With this information, 60 
care can be improved for those identified most at risk of death.   61 
 4 
Introduction 62 
Sepsis is defined as life threatening organ dysfunction resulting from a dysregulated host 63 
response to infection [1] and represents a significant burden to UK healthcare. Between 64 
5.1% and 7% of all deaths in the UK are associated with sepsis [2], costing the NHS 65 
£2.5 billion annually [3]. Sepsis is the second highest cause of mortality in the UK, with 66 
between 36,000 to 64,000 people dying per year [4].  67 
Following “unacceptably high” [5] mortality rates from sepsis (and associated historical 68 
terms severe sepsis), the Surviving Sepsis Campaign set out to standardise treatment 69 
through protocols. Early Goal Directed Therapy (EGDT) detailed interventions for treating 70 
patients with sepsis and their time-frame. After multiple permutations of the guidelines, 71 
and their latest revision in 2016, the current recommendations include time critical 72 
administration of antimicrobial therapy and cardiovascular resuscitation (target within 1 73 
hour and 3 hours respectively) [1]. Initial studies showed improved in hospital mortality 74 
for septic patients treated with EGDT [6]. However, subsequent research including three 75 
large clinical trials and their associated meta-analysis, have shown no significant 76 
improvement in patient outcome when using EGDT [7–10], undermining initial treatment 77 
strategies. 78 
Despite the overwhelming burden of the disease, slow progress on treatment strategies 79 
has prompted calls for further research into sepsis. In particular, more knowledge is 80 
required of the factors that increase the risk of death from sepsis, in order to guide 81 
treatment protocols and delivery of care, and ultimately reduce sepsis-associated 82 
mortality. This exploratory study aims to investigate patient factors, signs, symptoms 83 
and process of care and their association with 30 day mortality.  84 
  85 
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Methods 86 
Data was prospectively recorded between November 2011 and March 2014 on adult 87 
patients with sepsis presenting Nottingham University Hospitals NHS Trust, as part of an 88 
ongoing quality improvement project in managing sepsis since 2005.  Patients were 89 
identified as those admitted to the critical care department including the intensive care 90 
unit, and both the medical and surgical high dependency units with the diagnosis of 91 
sepsis [11]. Inclusion criteria were based on the penultimate consensus definition for 92 
severe sepsis, with presence of two or more signs of the systemic inflammatory response 93 
syndrome (SIRS) and one or more sign of organ dysfunction or tissue hypoperfusion 94 
with a background of proven or suspicion of infection. Confirmatory blood culture was 95 
not an inclusion criterion. Patients were excluded if they were transferred from another 96 
hospital with pre-existing sepsis.   97 
A dedicated sepsis team collected the information using a previously validated data 98 
collection tool [12]. Variables included patient demographics, symptoms of SIRS, 99 
markers of organ dysfunction or tissue hypoperfusion, source of sepsis, locations of early 100 
care, and time to interventions. These 97 variables were then assessed for association 101 
with 30 day mortality, the primary outcome (online supplement Table E1). Data on 30 102 
day mortality was collected routinely from the hospital administrative system, including 103 
both hospital and community deaths. Time zero was the time of the initial symptom, sign 104 
or indicator of organ dysfunction or tissue hypoperfusion due to severe sepsis. 105 
Basic characteristics were obtained using summary statistics and univariate analyses. 106 
Chi2 and Fisher’s exact test were used to assess categorical variables. Independent 107 
samples t-test and Mann-Whitney test were used for continuous data, as appropriate.  108 
A multi-variate model was built including all those variables that were significant 109 
predictors of 30 day mortality (p<0.05).  Those variables that that were no-longer 110 
significant were removed, then each non-significant variable was added individually to 111 
the model and keeping significant variables. Likelihood-ratio test determined the 112 
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significance of categorical variables in terms of 30 day mortality. For all tests, a 113 
significance level of p<0.05 was used.  All data was analysed in Stata (version 13) 114 
The data collection was registered under the Nottingham University Hospitals Audit 115 
Office, with the reference number 2890. Initial permission for data collection was 116 
granted in 2004, with an institutional waiver for informed consent. For analysis, data 117 
was anonymised, with all patient-identifiers removed from the database. 118 
Results 119 
455 patients were identified with severe sepsis, with 26.2% mortality. Age ranged from 120 
17 to 95 and mean age was 64.0 years (standard deviation=16.6). 42% of patients were 121 
female.  122 
Following univariate analysis for association with 30 day mortality (Online table E1-E11), 123 
fever (>38.3°C) (OR=0.35 95%CI=0.23-0.55), (Table E2, additional file), sepsis from 124 
skin infection (OR=0.34 95%CI=0.12-0.99), (Table E5, additional file), and not needing 125 
inotropes within 6 hours (OR=0.36 95%CI=0.15-0.89), (Table E10, additional file), were 126 
shown to be protective. Increased age (Table E1, additional file), hypothermia (core 127 
temperature <36°C) (OR=3.44 95%CI=1.83-6.45),  (Table E2, additional file), altered 128 
mental status (OR=1.88 95%CI=1.14-3.10), (Table E2, additional file), coagulation 129 
abnormalities (OR=2.94 95%CI=1.00-8.61), (Table E3, additional file), 130 
thrombocytopenia (platelet count <100x109/L) (OR=2.85 95%CI=1.32-6.15), (Table 131 
E3), mottling of the skin (OR=4.50 95%CI=1.55-13.08),  (Table E3, additional file), 132 
elevated serum lactate concentration (Table E8, additional file), remaining hypotensive 133 
after vasopressors (OR=3.80 95%CI=1.53-9.40),  (systolic blood pressure <90mmHg or 134 
mean arterial pressure <70mmHg) (Table E9, additional file) and hospital acquired 135 
sepsis (symptoms first shown >24hours after hospital admission with different 136 
diagnosis) (OR=1.80 95%CI=1.11-2.94), (Table E11, additional file) were shown to 137 
increase odds of 30 day mortality.  138 
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Multivariate analyses (Table 1) demonstrated increasing age (OR per year increase=1.05 139 
95%CI=1.03-1.07), thrombocytopenia (OR=3.10 95%CI=1.23-7.82), higher lactate 140 
value (OR per mmol increase=1.16 95%CI=1.06-1.27), remaining hypotensive after 141 
vasopressor treatment (OR=3.89 95%CI=1.26-11.95), hospital-acquired sepsis 142 
(OR=3.34 95%CI=1.78-6.27) and mottling (OR=3.80 95%CI=1.06-13.55) to be 143 
predictors of increased odds of 30 day mortality. In addition, fever (OR=0.46 144 
95%CI=0.28-0.75), being on a surgical ward at the time of sepsis presentation 145 
(OR=0.35 95%CI=0.15-0.81 and fluid refractory hypotension as defined by the 2008 146 
and subsequently 2012 Surviving Sepsis Campaign guidelines, (OR=0.29 95%CI=0.10-147 
0.87) were shown to be protective against 30 day mortality. No process of care factors 148 
was significant in either univariate or multivariate analysis.  149 
Table 1: Multivariate logistic regression model indicating variables significantly 150 
associated with 30 day mortality 151 
Variable ORa AdjOR* 95%CIb p-value 
Age (per year) 
 
1.05 1.03-1.07 <0.001 
Temperature >38.3°C 0.35 0.46 0.28-0.75 0.002 
Thrombocytopenia (<100x109/L) 2.85 3.10 1.23-7.82 0.016 
Hospital-acquired sepsis 1.80 3.34 1.78-6.27 <0.001 
Lactate Value (per mmol/L) 
 
1.16 1.06-1.27 0.001 
Fluid Refractory Hypotensionc 0.60 0.29 0.10-0.87 0.027 
Remain in Hypotensive Statecd 3.80 3.89 1.26-11.95 0.02 
Surgical Ward at Time Zero 0.57 0.35 0.15-0.81 0.015 
Mottling of the skin 4.50 3.80 1.06-13.55 0.04 
a Odds Ratio 152 
*Adjusted Odds Ratio- mutually adjusted for everything in the table 153 
b95% Confidence Interval 154 
c Persistent systolic blood pressure <90mmHg or mean arterial pressure <70mmHg despite fluid 155 
resuscitation 156 
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d15 patients missing data 157 
 158 
Discussion 159 
Although there were a number of factors investigated, only 9 variables were predictors 160 
of 30 day mortality, and none of these were process of care variables such as timeliness 161 
of care, or seniority of doctor. Important predictors were increased age, 162 
thrombocytopenia (<100x109), hospital-acquired sepsis, increased serum lactate 163 
concentration, remaining hypotensive following vasopressors and mottling of the skin, all 164 
of which increased odds of 30 day mortality. In our data set, temperature >38.3°C, fluid 165 
refractory hypotension and being on a surgical ward were protective against 30 day 166 
mortality. With the exception of fluid refractory hypotension proving significantly 167 
protective, these variables are largely consistent with other research(13–15).  168 
Age 169 
There are two reasons why older age may be associated with increased mortality in 170 
patients with sepsis. First, with increased age is associated with decreased lymphocyte 171 
function, causing weakened immune responses [16]. This is compounded by poor 172 
nutritional status and altered cytokine response [17]. The second possibility is that older 173 
patients have more comorbidities (itself an independent risk factor for death from sepsis 174 
[18]).  175 
Temperature >38.3°C  176 
Fever may be associated with improved outcomes for both pathophysiological and care-177 
process reasons. Fever has been associated with better outcomes in other studies 178 
including the FACE Study Group [13], which found the odds ratio for mortality associated 179 
with fever (37.5°C-38.4°C) was 0.45 (p=0.014), almost identical to the odds ratio found 180 
in this research. Fever enhances immune cell activity, with increased cytokine production 181 
[19], and inhibits pathogen growth, improving survival [13,20,21]. Additionally, as a 182 
widely recognised symptom and sign of sepsis even amongst non-healthcare 183 
professionals, fever may result in earlier recognition and faster treatment, which may in 184 
turn be beneficial for survival.  185 
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 186 
Thrombocytopenia (<100x109/L) 187 
The finding that thrombocytopenia was significantly associated with 30 day mortality in 188 
septic patients, with an odds ratio of 3.1, is supported by other research [22–24]. Lee et 189 
al found that platelet count was significantly higher in survivors of sepsis than those who 190 
died (194+/-27x109/L versus 97+/-18x109/L, p<0.004), concluding also that 191 
thrombocytopenia is an independent risk factor for mortality in septic patients. Indeed 192 
low platelet count is included as a marker of poor prognosis in the SOFA score 193 
(sequential organ failure assessment), used to assess severity of organ failure [25].  194 
Lactate value 195 
Elevated lactate is either a marker of reduced global perfusion and tissue hypoxia with 196 
associated anaerobic cellular respiration or reduced hepatic clearance of lactate [26]. 197 
Previous studies have shown a linear relation between increased lactate and increased 198 
mortality [14], in accordance with our finding that increased serum lactate is a marker 199 
poor prognosis. 200 
Mottling of the skin 201 
Mottling (livedo reticularis) is caused by peripheral blood vessel constriction [15]. 202 
Previous studies have demonstrated an association between skin mottling and mortality 203 
[15,27]. One theory suggests that mottling reflects microvascular abnormalities, 204 
associated with organ dysfunction from microvascular shunting and hypoperfusion, and 205 
therefore increased mortality from multiple organ failure.  206 
Fluid refractory hypotension (septic shock) 207 
In this study, the mortality rate of patients with septic shock at 30 days was 23.9%, 208 
which is at the lower end of previous mortality estimates (22%-50%(28,29)). However, 209 
these studies above do not distinguish between patients who did not respond to 210 
vasopressor therapy, found to increase odds of 30 day mortality (see below), and 211 
 10 
patients who did respond. Therefore, the difference in observed mortality rates may be 212 
explained by the proportion of patients who remained hypotensive after receiving fluid 213 
and subsequent vasopressors. Another plausible arugment of the apparently protective 214 
characteristic of septic shock is that it may represent the beneficial effect of expedient 215 
transfer of patients into critical care to receive vasopressor therapy, which is otherwise 216 
unavailable within the hospital. In this data set, 247 patients remained hypotensive after 217 
fluid therapy, with a median average time of admission to critical care of 6 hours (inter 218 
quartile rage [IQR] 3.86-10 hours) compared to 97 patients who responded to fluid with 219 
a median average admission time of 7 hours (IQR 4.25-14.3 hours). The wide range of 220 
times and presence of outliers; fluid refractory 0-80 hours, and fluid responsive 0-244 221 
helps to explain why this demonstrated a trend towards statistical significance with 222 
p=0.0527. 223 
Remaining hypotensive after vasopressor treatment  224 
Fluid and vasopressor refractory hypotension was associated with increased mortality. In 225 
combination with the previous finding that fluid refractory hypotension was protective, 226 
this may indicate that prognosis is only poor in patients with septic shock, who fail to 227 
respond to vasopressors.  228 
Hospital-acquired sepsis 229 
The care of septic patients admitted to critical care from wards rather than emergency 230 
departments seems to be less well established, leading to higher in-hospital mortality 231 
[30]. This supports our findings of an increased 30 day mortality in patients diagnosed 232 
with severe sepsis on wards rather than from emergency admission areas such as the 233 
Emergency Department or acute admission unit. Additionally, comorbidity and reason for 234 
hospital stay may itself cause higher mortality within this population.  235 
Patient on surgical ward at time of diagnosis of sepsis 236 
Diagnosis of sepsis in patients on a surgical was found to be associated with a reduction 237 
in 30 day mortality. Surgical patients may have a source of sepsis more amenable to 238 
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source control through surgical management, such as debridement or drainage, 239 
improving survival prospects compared to medical patients in whom source control is 240 
impossible to achieve, for example in severe pneumonia. Additionally, as sepsis is a 241 
known complication of surgery [31,32], it is also possible that clinicians are more 242 
receptive of the signs and symptoms necessary to facilitate rapid diagnosis.  243 
Process of Care Factors 244 
Process of care factors, such as time delay to be seen, seniority of assessing clinician, 245 
and time delay to intervention were not found to significantly affect 30 day mortality. 246 
This  contradicts much of the early research into sepsis care [6,33,34], which formed the 247 
foundations of EGDT and subsequent sepsis care bundles. However, recent research 248 
including a systematic review [10] of three large clinical trials [7–9] also found no 249 
significance between mortality and EGDT. It also must be considered that the apparent 250 
lack of significance between the process of care factors and 30-day mortality may be due 251 
to the low variability of care provided at our institution following over a decade of service 252 
improvement in the care of patients with sepsis. This has included hospital wide 253 
screening systems, multi-specialty and multi-disciplinary education programs, audit and 254 
performance related feedback by a dedicated sepsis team. Therefore, whilst these 255 
process factors such as time to treatment may still be significant with large variation in 256 
practice, this was not detectable in this study. This is reinforced by the recent findings of 257 
Seymour and colleagues [35].  258 
Strengths and limitations 259 
Exclusion criteria were minimised, making the study population representative of 260 
patients in Nottingham. As the fourth largest acute trust in the UK, the results of this 261 
study are highly generalizable to the rest of the UK. Missing data was low and the study 262 
took place in a real-world setting. Data collection was carried out by a trained and 263 
dedicated sepsis team with over a decade of experience in using the data collection 264 
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tools. It is important to note that this sepsis team were not involved in treatment of 265 
these patients. 266 
Limitations of this study include the large number of tests carried out, increasing chance 267 
of false positive findings. If Bonferroni correction was applied only those results with a p-268 
value of <0.0005 would be considered significant. This work was carried out as an 269 
exploratory study and therefore further work with larger data sets would be required to 270 
confirm the findings of interest. For the duration of this work, the historical penultimate 271 
sepsis definitions were used [11]. Although the term severe sepsis is no longer used and 272 
the definition of septic shock has changed, it is felt that the results of this study are still 273 
applicable as the core disease processes underpinning the definition have not changed. 274 
It is important to realise a significant limitation of this study is the apparent selection 275 
bias involved in patient identification of only those admitted to critical care areas with 276 
the diagnosis of sepsis. This risks omitting a group of patients who were treated 277 
appropriately with good response demonstrating early resolution of organ dysfunction. 278 
However, this method of identification yields similar numbers compared to previous work 279 
at Nottingham University Hospitals NHS Trust [12], this may be explained by evolving 280 
practice in terms of managing patient acuity, disease severity and patient flow through 281 
the hospital pathways such that a greater proportion of unwell patients are managed on 282 
critical care than a decade ago. 283 
Conclusion 284 
In conclusion, this exploratory analysis presents the factors significantly associated with 285 
30 day mortality in patients diagnosed with sepsis. Results suggest importance of patient 286 
factors associated with mortality. Age, thrombocytopenia, remaining hypotensive after 287 
vasopressor administration, hospital-acquired sepsis, increased serum-lactate 288 
concentration and mottling all increased odds of 30 day mortality. Presentation on a 289 
surgical ward, fever and septic shock were found to be protective. This paper highlights 290 
some interesting risk factors associated with mortality from sepsis, indicating the 291 
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direction of further research, particularly into the seldom researched matter of hospital 292 
acquired sepsis.  293 
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